Dermatology · Bayonne, NJ
NPI
1326102609
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
844 Avenue C
Bayonne, NJ, 07002
Phone (201) 339-6681
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
2,804 services
Medicare patients, 2024
251
Average age 74
Drug cost, 2024
$3.1M
4,639 prescriptions
Company payments, 2025
$1,179
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Liliya Besedina was code 99213 (office e&m - established), 307 times for 174 patients. In total Liliya Besedina billed 2,804 services in 26 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 307 | 174 | $76.68 | $24K |
| 17110 Destruction Skin Lesion | Office | 82 | 62 | $98.79 | $8,101 |
| 11102 Skin Biopsy | Office | 72 | 58 | $81.90 | $5,897 |
| 99203 Office E&M - New | Office | 72 | 72 | $87.69 | $6,314 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 59 | 13 | $0.69 | $40.77 |
| 17000 Destruction Skin Lesion | Office | 36 | 24 | $47.47 | $1,709 |
| 11103 Skin Biopsy | Office | 21 | 15 | $47.32 | $994 |
| 99212 Office E&M - Established | Office | 18 | 16 | $49.53 | $891 |
By year: 2022 $23K for 378 services; 2023 $33K for 908 services; 2024 $59K for 2,804 services.
Medicare prescription drug claims, 2024
In 2024, the drug Liliya Besedina prescribed most often to Medicare patients was Fluocinonide, with 425 prescriptions and refills. In total Liliya Besedina wrote 4,639 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluocinonide Generic | 425 | 425 | 32 | $40K |
| Ammonium Lactate Generic | 351 | 372 | 149 | $8,771 |
| Metronidazole Generic | 292 | 318 | 100 | $26K |
| Ketoconazole Generic | 271 | 288 | 95 | $8,465 |
| Finasteride Generic | 264 | 402 | 74 | $342 |
| Clobetasol Propionate Generic | 221 | 232 | 90 | $26K |
| Finacea Azelaic Acid | 179 | 179 | 74 | $74K |
| Mupirocin Generic | 144 | 144 | 120 | $810 |
| Opzelura Ruxolitinib Phosphate | 138 | 144 | 53 | $266K |
| Pimecrolimus Generic | 138 | 150 | 50 | $42K |
| Fluocinolone Acetonide Generic | 134 | 141 | 57 | $4,808 |
| Azelaic Acid Generic | 113 | 127 | 41 | $7,579 |
| Jublia Efinaconazole | 101 | 101 | 25 | $134K |
| Zoryve Roflumilast | 95 | 95 | 30 | $96K |
| Halobetasol Propionate Generic | 93 | 93 | 47 | $5,224 |
Brand drugs: 1,129 claims; generic drugs: 3,510 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Liliya Besedina $1,179 ($1,179 in general payments such as food, travel and fees) from 16 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $199.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 12 | $199 |
| Abbvie Inc. ABBV | 9 | $180 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $163 |
| Mayne Pharma Commercial LLC | 8 | $142 |
| Organon LLC OGN | 5 | $102 |
| Incyte Corporation INCY | 4 | $74.8 |
| LEO Pharma Inc. | 2 | $57.89 |
| Amgen Inc. AMGN | 2 | $46.31 |
| Lilly USA, LLC LLY | 2 | $44.68 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $35.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.